BADAS has introduced the app with the support of Novo Nordisk
An app was rolled out on Saturday by the Diabetic Association of Bangladesh (BADAS) that will allow doctors to see the chronology of a diabetic patient's treatment.
Called "Diabetes Journey", the app will work based on the Diabetes Care BADAS guideline, which is prepared jointly by BADAS and Non-Communicable Diseases Control Programme of Directorate General of Health Services.
BADAS has introduced the app with the support of Novo Nordisk.
A countrywide training programme will be rolled out for the physicians on how to use this application.
Users of the app must enter at least one of the following glucose values in the app such as Fasting Plasma Glucose, Glycated Hemoglobin, Random Plasma Glucose, Oral Glucose Tolerance Test/ Postprandial glucose.
The result will be found at the bottom of the screen where it will describe the patient’s glucose measurement value as “Normal”, “Prediabetes – Begin lifestyle interventions” or “Diabetes – begin lifestyle interventions and medical treatment”.
Based on the patient details, the app will provide guideline-based recommendations including the following actions, discontinuation of medications, that may harm the patient, initiation of oral antidiabetic drugs (OAD), titration of OAD's, intensification of OAD’s, initiation of injectable antidiabetic drugs, titration of injectable antidiabetic drugs, intensification of injectable antidiabetic drugs and replacement of medication.
The application and guideline are developed as a supporting tool for physicians and to empower them to select the right medication for patients living with diabetes, said AK Azad Khan, president of BADAS.
Improving the treatment capacity of the doctors is also a demand of the time and these initiatives are aligned with modernising the treatment of diabetes management, said Md Robed Amin, line director of NCD Control Programme of DGHS.
The diabetes journey application and the country’s first nationwide diabetes patients’ registry are few examples of digitalisation in Bangladesh and are aligned with the government’s vision for “Digital Bangladesh”, said Md Sayef Uddin, secretary general of BADAS.
Before its launch, Diabetes Journey was placed on Google Play Store for a test run last week. Its officials said that the app was downloaded more than 1,000 times by the doctors, BADAS officials said.
The high volume of download says that the app is in high demand among doctors, said Gazi Towhid Ahmed, public affairs manager of Novo Nordisk Bangladesh.